generic glp-1 receptor agonists America's Poison Centers GLP-1s and Hormone Therapy: A
Description
Diabetologia 2016
This pattern continued when assessing the risk for atrial fibrillation, as the GLP-1 group had a significantly decreased risk for this outcome vs
Coverage for obesity indications (Wegovy, Saxenda, Zepbound) remains more limited
Weight loss improves knee OA, with studies showing a 2% improvement in the WOMAC pain, function, and stiffness scores for every 1% reduction in body weight
Common examples : Semaglutide (Ozempic, Wegovy) Liraglutide (Victoza, Saxenda) Dulaglutide (Trulicity) Tirzepatide (dual GLP-1/GIP agonist Mounjaro) How They Help in Diabetes
Ahern T, Tobin AM, Corrigan M, et al
